Company Description
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.
It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves.
It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.
Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
| Country | United States |
| Founded | 1995 |
| IPO Date | Oct 1, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 291 |
| CEO | Glendon French |
Contact Details
Address: 700 Chesapeake Drive Redwood City, California 94063 United States | |
| Phone | 650 364 0400 |
| Website | pulmonx.com |
Stock Details
| Ticker Symbol | LUNG |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $19.00 |
| CIK Code | 0001127537 |
| CUSIP Number | 745848101 |
| ISIN Number | US7458481014 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Glendon E. French | Chief Executive Officer, President and Director |
| David A. Lehman J.D. | General Counsel and Secretary |
| Steven S. Williamson | Advisor |
| Mehul Joshi | Advisor |
| Dr. Derrick Sung Ph.D. | Chief Financial Officer and Chief Operating Officer |
| Sri Radhakrishnan | Chief Technical Officer |
| Marcee M. Maroney | Vice President of Marketing |
| Sarah Huber | Vice President of Sales (U.S.) |
| Lisa Paul | Chief People Officer |
| Jérôme Erath | Senior Vice President and GM of International |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 25, 2025 | EFFECT | Notice of Effectiveness |
| Nov 24, 2025 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Nov 24, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 13, 2025 | SCHEDULE 13G/A | Filing |
| Nov 12, 2025 | 10-Q | Quarterly Report |
| Nov 12, 2025 | 8-K | Current Report |
| Nov 7, 2025 | SCHEDULE 13G/A | Filing |
| Oct 27, 2025 | 8-K | Current Report |
| Sep 26, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Sep 8, 2025 | SCHEDULE 13G/A | Filing |